Embracing synthetic lethality of novel anticancer therapies.

about

Reverse the Resistance to PARP Inhibitors.

P2860

Q37675896-A871B111-1D25-4BA8-A4E0-12A064C73897

P2860

Embracing synthetic lethality of novel anticancer therapies.

Item

http://www.wikidata.org/entity/Q38554530

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Embracing synthetic lethality of novel anticancer therapies.

@en

type

Item

label

Embracing synthetic lethality of novel anticancer therapies.

@en

prefLabel

Embracing synthetic lethality of novel anticancer therapies.

@en

P1476

Embracing synthetic lethality of novel anticancer therapies.

@en

P2093

Ahmed Kamal

http://www.w3.org/2001/XMLSchema#string

Mohammed Shaheer Malik

http://www.w3.org/2001/XMLSchema#string

Thokhir Basha Shaik

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

BRCAness: finding the Achilles heel in ovarian cancer

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

Targeting DNA damage response in cancer therapy

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.

Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.

The concept of synthetic lethality in the context of anticancer therapy

Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens.

P304

1119-1132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2015.1072167

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280497506

http://www.w3.org/2001/XMLSchema#string

P698

26211783

http://www.w3.org/2001/XMLSchema#string

Embracing synthetic lethality of novel anticancer therapies.

about

P2860

P2860

Embracing synthetic lethality of novel anticancer therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698